SLC17A7 and Alzheimer disease: Several studies have shown that alterations in expression of vesicular glutamate transporters impact various brain disorders including schizophrenia, Parkinson's disease and Alzheimer's disease; moreover, a recent study has shown increased expression of Slc17a7 in the white matter of schizophrenic patients [44], [45].